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Modern people are still influenced by the mind-body
dualism of Rene Descartes. Some of these people said
“Anxiety aggravated the symptoms of these patients,” a
notion that most people probably consider natural. By
contrast, I would like to criticize this concept because
anxiety is posited as an independent driving force that
actively changes one’s body. However, anxiety per se is a
subjective feeling produced by the brain and somatic
signals from the body. Actually, neural activities in the
central and autonomic nervous systems along with
endocrine and immune function change the body. From
this point of view, anxiety is not the CAUSE of mind-
body changes but the RESULT of them. The origin and
synthetic processing of emotion are more important
than simple idea that the “mind” directly changes the
body. Descartes’ mind-body dualism conceals, in our
view, how diseases should be recognized and analyzed.
Functional gastrointestinal disorders are useful for
illustrating how the rationale of “nervism” of my notion
is manifest. In particular, irritable bowel syndrome (IBS)
is a prototype of functional gastrointestinal disorders
[1], and the biopsychosocial model is well fit to IBS [1].
Although genes, inflammation, gut microbiota, psycho-
social stress, and early learning may play an important
role in the pathogenesis of IBS [2,3], brain-gut interac-
tions cannot be excluded from the pathophysiology of
IBS [4]. Brain imaging studies have clarified the roles of
the anterior cingulate cortex, amygdala, insula and the
brain stem in response to visceral stimulation [2,5,6].
These structures produce both visceral pain and nega-
tive emotion that are typical symptoms of IBS patients.
Some researchers interpret the anxiety and depression
of IBS patients as “noise” or “confounding factors” that
require control. However, IBS patients naturally have
negative emotion. Some IBS patients may not have anxi-
ety or depression at the clinically diagnostic level, but a
high percentage of IBS patients show increased levels of
anxiety and depression. Therefore, the concept that
“pure IBS” pathophysiology is completely separated from
anxiety and depression is influenced by the Descartes’
mind-body dualism and may hinder our ability to see
the true nature of the mind-body relationship.
The clinical usefulness of psychological treatments for
IBS patients is evidence of the rationale of the biopsy-
chosocial model. The theoretical background of psy-
chotherapies for IBS is as follows. First, IBS patients
have deranged life styles characterized by more per-
ceived stress, more irregular sleep and more irregular
meals [7]. Reduction of these risk factors is the first step
to minimize the exacerbating factors of IBS. Second, the
doctor-patient relationship is important for effective
treatment. A positive physician-patient interaction is
associated with a good prognosis of IBS [8]. Third, the
close relationship between daily stress or hassles and
IBS symptoms is present [9]. The stress response should
be managed. Fourth, IBS patients show high response to
placebo [10]. This phenomenon means that suggestion
and expectation greatly influence the therapeutic effect.
Fifth, IBS patients have high levels of anxiety, depres-
sion, and somatization [11]. Not only neuropharma-
cotherapies but also psychotherapies are indispensable
for these co-morbid disorders whose improvement often
alleviates IBS symptoms. Sixth, intractable IBS patients
have often experienced traumatic life events [12].
Improved brain function has been reported after treat-
ment including psychotherapy [13]. Seventh, the effects
of health beliefs and learned behaviors may adversely
affect outcome.
There is evidence from a systematic review and meta-
analysis of rigorously executed trials on IBS that psycho-
logical treatment in general is effective for IBS [14].
Hypnotherapy is a representative strategy for refractory
IBS [15]. Autogenic training is auto-hypnosis with the
goal of being able to self-administer suggestions of
relaxation. We reported that autogenic training is effec-
tive for intractable IBS patients [16]. Cognitive-beha-
vioral therapy (CBT) focuses on ways to increase or
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thoughts and irrational beliefs. CBT was found to be
more effective than an educational intervention [17].
Psychological treatments are interpreted as how humans
have been influenced by others. During psychological
treatments, function of the specific brain regions in
patients is altered. Good examples are the decreased
activities of the anterior cingulate cortex during hypno-
tic modulation of pain [18] and the increased activities
of the anterior cingulate cortex during empathy to pain
[19]. Therefore, how neural processing of interoception
is modified after the activation of specific brain regions,
including the mirror neuron system, should be explored.
Further research on neurological approaches to biopsy-
chosocial medicine will be valuable.
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